Jove
Visualize
联系我们

相关概念视频

Antibiotic Selection00:57

Antibiotic Selection

52.9K
Overview
52.9K
Bacterial Signaling01:30

Bacterial Signaling

31.9K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
31.9K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

70.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Encapsulation-enhanced switchable protein release from engineered probiotic lactobacilli.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

Developing an <i>In Vitro</i> Model of Endotoxemia to Assess the Immunomodulatory Effects of Anti-Inflammatory Peptide-Secreting Living Therapeutics.

ACS pharmacology & translational science·2025
Same author

Adaptations of Gram-Negative and Gram-Positive Probiotic Bacteria in Engineered Living Materials.

ACS biomaterials science & engineering·2025
Same author

Engineered microbial living matter for diagnostics, prevention, and therapy.

Current opinion in biotechnology·2025
Same author

PEARL: Protein Eluting Alginate with Recombinant Lactobacilli.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

A screening setup to streamline <i>in vitro</i> engineered living material cultures with the host.

Materials today. Bio·2025
Same journal

Smart biomaterials: From responsiveness to closed-loop sensing and feedback.

Trends in biotechnology·2026
Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026
Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
查看所有相关文章
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 20, 2025

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials
10:28

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Published on: March 9, 2017

8.9K

使用材料溶液的工程细菌疗法.

Sourik Dey1, Shrikrishnan Sankaran1

  • 1INM - Leibniz Institute for New Materials, Campus D2 2, 66123 Saarbrücken, Germany.

Trends in biotechnology
|July 19, 2024
PubMed
概括
此摘要是机器生成的。

工程细菌显示出疾病治疗的希望,但水凝封装是提高其生存,疗效和临床使用安全性的关键.

关键词:
生物材料是一种生物材料.药物输送是药物输送的过程.这种水凝是水凝.生活治疗药物生活治疗药物合成生物学 合成生物学

更多相关视频

Bioluminescent Bacterial Imaging In Vivo
05:06

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

15.3K
Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon
15:28

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Published on: November 16, 2012

14.5K

相关实验视频

Last Updated: Jun 20, 2025

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials
10:28

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Published on: March 9, 2017

8.9K
Bioluminescent Bacterial Imaging In Vivo
05:06

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

15.3K
Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon
15:28

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Published on: November 16, 2012

14.5K

科学领域:

  • 生物医学工程 生物医学工程
  • 微生物学 微生物学
  • 材料科学 材料科学 材料科学

背景情况:

  • 工程细菌疗法提供有针对性的,活体疾病干预,在早期临床试验中显示出潜在的潜力.
  • 证明有效性和确保生物安全的挑战阻止了工程治疗细菌的监管批准.
  • 材料科学提供了解决方案,凝封装成为一个有前途的战略.

研究的目的:

  • 审查使用水凝封装用于工程细菌治疗的跨学科方法.
  • 要突出水凝如何增强细菌的生存,有效性和安全性.
  • 讨论活体治疗材料在临床转化中的潜力.

主要方法:

  • 审查工程细菌治疗的最新进展.
  • 对细菌输送的水凝封装技术的分析.
  • 讨论在治疗细菌中的材料科学创新.

主要成果:

  • 水凝封装保护细菌免受生理压力.
  • 封装使治疗剂的控制释放成为可能.
  • 水凝防止了细菌的意外传播,提高了生物安全性.

结论:

  • 水凝封装是一种可行的策略,可以克服工程细菌疗法的关键挑战.
  • 这种方法可以重新定义活细菌疗法的交付和功能.
  • 由水凝促进的活体治疗材料显示出临床翻译的巨大潜力.